

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.93961729 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.76822041 |
| 3 | glutamate receptor signaling pathway (GO:0007215) | 5.52333363 |
| 4 | vocalization behavior (GO:0071625) | 5.51272662 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.33444512 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.28109285 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.26250365 |
| 8 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.23503850 |
| 9 | neuronal action potential propagation (GO:0019227) | 5.22366248 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.17001059 |
| 11 | protein localization to synapse (GO:0035418) | 5.00966341 |
| 12 | synaptic transmission, glutamatergic (GO:0035249) | 4.96568169 |
| 13 | locomotory exploration behavior (GO:0035641) | 4.84111446 |
| 14 | neuron-neuron synaptic transmission (GO:0007270) | 4.64357113 |
| 15 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.64216479 |
| 16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.62288358 |
| 17 | synaptic vesicle maturation (GO:0016188) | 4.49780070 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.49751755 |
| 19 | regulation of beta-amyloid formation (GO:1902003) | 4.48400194 |
| 20 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.47677283 |
| 21 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.40116986 |
| 22 | glutamate secretion (GO:0014047) | 4.39154072 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 4.37015071 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.32589064 |
| 25 | long-term memory (GO:0007616) | 4.32202500 |
| 26 | exploration behavior (GO:0035640) | 4.30687375 |
| 27 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.30228355 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 4.23099907 |
| 29 | L-amino acid import (GO:0043092) | 4.18901317 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.18780410 |
| 31 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.12987046 |
| 32 | positive regulation of membrane potential (GO:0045838) | 4.08591489 |
| 33 | positive regulation of synapse maturation (GO:0090129) | 4.07556361 |
| 34 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.01565574 |
| 35 | synaptic vesicle endocytosis (GO:0048488) | 4.01512860 |
| 36 | regulation of postsynaptic membrane potential (GO:0060078) | 4.00720685 |
| 37 | neurotransmitter secretion (GO:0007269) | 4.00450553 |
| 38 | neurotransmitter uptake (GO:0001504) | 3.94803524 |
| 39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.93172550 |
| 40 | cellular potassium ion homeostasis (GO:0030007) | 3.91531111 |
| 41 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.87253991 |
| 42 | presynaptic membrane assembly (GO:0097105) | 3.87003152 |
| 43 | postsynaptic membrane organization (GO:0001941) | 3.86304622 |
| 44 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.85264371 |
| 45 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.84390956 |
| 46 | long-term synaptic potentiation (GO:0060291) | 3.79958198 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.73145285 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.66684110 |
| 49 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.66442842 |
| 50 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.64299202 |
| 51 | response to histamine (GO:0034776) | 3.63604322 |
| 52 | behavioral defense response (GO:0002209) | 3.63604292 |
| 53 | behavioral fear response (GO:0001662) | 3.63604292 |
| 54 | positive regulation of dendritic spine development (GO:0060999) | 3.60822781 |
| 55 | protein prenylation (GO:0018342) | 3.56679706 |
| 56 | prenylation (GO:0097354) | 3.56679706 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.56445513 |
| 58 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.52757820 |
| 59 | presynaptic membrane organization (GO:0097090) | 3.51447303 |
| 60 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.48140233 |
| 61 | gamma-aminobutyric acid transport (GO:0015812) | 3.47883434 |
| 62 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.47543691 |
| 63 | membrane depolarization (GO:0051899) | 3.47485108 |
| 64 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.44237972 |
| 65 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.43118096 |
| 66 | fear response (GO:0042596) | 3.42933854 |
| 67 | C4-dicarboxylate transport (GO:0015740) | 3.42460607 |
| 68 | membrane depolarization during action potential (GO:0086010) | 3.40272195 |
| 69 | neurotransmitter transport (GO:0006836) | 3.39846365 |
| 70 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.39556447 |
| 71 | regulation of synapse maturation (GO:0090128) | 3.39472056 |
| 72 | potassium ion import (GO:0010107) | 3.38843987 |
| 73 | transmission of nerve impulse (GO:0019226) | 3.36919511 |
| 74 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.35906578 |
| 75 | regulation of synapse structural plasticity (GO:0051823) | 3.35092806 |
| 76 | retinal cone cell development (GO:0046549) | 3.33568866 |
| 77 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.33056247 |
| 78 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.32524837 |
| 79 | learning (GO:0007612) | 3.30944113 |
| 80 | neuron recognition (GO:0008038) | 3.30777715 |
| 81 | regulation of vesicle fusion (GO:0031338) | 3.27087535 |
| 82 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.25721554 |
| 83 | regulation of neurotransmitter secretion (GO:0046928) | 3.25271243 |
| 84 | detection of calcium ion (GO:0005513) | 3.23871057 |
| 85 | cell communication by electrical coupling (GO:0010644) | 3.22274322 |
| 86 | cerebellar granule cell differentiation (GO:0021707) | 3.22241668 |
| 87 | negative regulation of Ras GTPase activity (GO:0034261) | 3.21532284 |
| 88 | positive regulation of neurotransmitter transport (GO:0051590) | 3.19961616 |
| 89 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.19834979 |
| 90 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.19641616 |
| 91 | amino acid import (GO:0043090) | 3.18008606 |
| 92 | proline transport (GO:0015824) | 3.16503473 |
| 93 | innervation (GO:0060384) | 3.13808123 |
| 94 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.13321202 |
| 95 | synaptic transmission (GO:0007268) | 3.12970853 |
| 96 | neuromuscular process controlling posture (GO:0050884) | 3.12308865 |
| 97 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.10975192 |
| 98 | regulation of synaptic transmission (GO:0050804) | 3.10664740 |
| 99 | chemosensory behavior (GO:0007635) | 3.10423125 |
| 100 | regulation of neurotransmitter levels (GO:0001505) | 3.10259212 |
| 101 | long term synaptic depression (GO:0060292) | 3.07594764 |
| 102 | dendritic spine morphogenesis (GO:0060997) | 3.06470227 |
| 103 | regulation of dendritic spine development (GO:0060998) | 3.05735238 |
| 104 | relaxation of cardiac muscle (GO:0055119) | 3.05627002 |
| 105 | startle response (GO:0001964) | 3.05508687 |
| 106 | sodium ion export (GO:0071436) | 3.04321980 |
| 107 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.03750597 |
| 108 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.03393468 |
| 109 | positive regulation of synaptic transmission (GO:0050806) | 3.03131920 |
| 110 | regulation of neurotransmitter transport (GO:0051588) | 3.01347667 |
| 111 | negative regulation of heart contraction (GO:0045822) | 2.99920090 |
| 112 | central nervous system myelination (GO:0022010) | 2.99169003 |
| 113 | axon ensheathment in central nervous system (GO:0032291) | 2.99169003 |
| 114 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.98470195 |
| 115 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.97800196 |
| 116 | memory (GO:0007613) | 2.94736420 |
| 117 | righting reflex (GO:0060013) | 2.94192809 |
| 118 | cellular sodium ion homeostasis (GO:0006883) | 2.93941367 |
| 119 | regulation of neuron projection regeneration (GO:0070570) | 2.93267613 |
| 120 | regulation of axon regeneration (GO:0048679) | 2.93267613 |
| 121 | regulation of cell communication by electrical coupling (GO:0010649) | 2.93212625 |
| 122 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.92966484 |
| 123 | protein localization to cilium (GO:0061512) | 2.91350377 |
| 124 | associative learning (GO:0008306) | 2.90748839 |
| 125 | neuronal ion channel clustering (GO:0045161) | 2.90547487 |
| 126 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.90541142 |
| 127 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.89808782 |
| 128 | negative regulation of heart rate (GO:0010459) | 2.89453910 |
| 129 | potassium ion homeostasis (GO:0055075) | 2.89104970 |
| 130 | synaptic vesicle transport (GO:0048489) | 2.88601119 |
| 131 | establishment of synaptic vesicle localization (GO:0097480) | 2.88601119 |
| 132 | synapse assembly (GO:0007416) | 2.88551678 |
| 133 | negative regulation of neurotransmitter transport (GO:0051589) | 2.86549079 |
| 134 | cell communication involved in cardiac conduction (GO:0086065) | 2.86501939 |
| 135 | acidic amino acid transport (GO:0015800) | 2.84913831 |
| 136 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.82704497 |
| 137 | regulation of cellular amide metabolic process (GO:0034248) | 2.79061745 |
| 138 | regulation of actin filament-based movement (GO:1903115) | 2.71900543 |
| 139 | regulation of platelet aggregation (GO:0090330) | 2.68216226 |
| 140 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.68169252 |
| 141 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.68039844 |
| 142 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.67944790 |
| 143 | serotonin metabolic process (GO:0042428) | 2.67580607 |
| 144 | mechanosensory behavior (GO:0007638) | 2.64574876 |
| 145 | relaxation of smooth muscle (GO:0044557) | 2.64418503 |
| 146 | regulation of female receptivity (GO:0045924) | 2.62334060 |
| 147 | L-glutamate transport (GO:0015813) | 2.59814354 |
| 148 | relaxation of muscle (GO:0090075) | 2.58856724 |
| 149 | auditory behavior (GO:0031223) | 2.58759119 |
| 150 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.52328923 |
| 151 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.52328923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.93991415 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.57089174 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.21291936 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15371735 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.07206544 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.88004424 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79233526 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.75966904 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.64247980 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.59268906 |
| 11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56589257 |
| 12 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56589257 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.56500107 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.42970470 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.40335761 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39673307 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39175366 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35876294 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29956238 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.27999792 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.27634660 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.17068670 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13084167 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12981033 |
| 25 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12324823 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07619729 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05505343 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.01456745 |
| 29 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.97677166 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95759025 |
| 31 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.95500171 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.93412010 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91677900 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91385520 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84597357 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.81646960 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.79301947 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78697761 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76862920 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75395316 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69249223 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69123545 |
| 43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.65045485 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.62476612 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58499450 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57686113 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55747383 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.55276085 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49921468 |
| 50 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49737061 |
| 51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47162049 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43055260 |
| 53 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40317448 |
| 54 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.40317448 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.38264441 |
| 56 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37561113 |
| 57 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.37399751 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37178064 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35926062 |
| 60 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34986735 |
| 61 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33354376 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32975779 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32250857 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29684428 |
| 65 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.29391765 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.27795116 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27368025 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26550786 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26549177 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25801280 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22293318 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20533474 |
| 73 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20369360 |
| 74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18794593 |
| 75 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18654743 |
| 76 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.17812427 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16911574 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16188555 |
| 79 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15620184 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14573046 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14529289 |
| 82 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13924581 |
| 83 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13628855 |
| 84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12794192 |
| 85 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10236063 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09766559 |
| 87 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08646755 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08486646 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08142149 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07936588 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 1.06880320 |
| 92 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05955924 |
| 93 | * AR_19668381_ChIP-Seq_PC3_Human | 1.05944663 |
| 94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05657651 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05090701 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04369180 |
| 97 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04000522 |
| 98 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03340453 |
| 99 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02677539 |
| 100 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02579917 |
| 101 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01619207 |
| 102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01291125 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00980070 |
| 104 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99912627 |
| 105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99311359 |
| 106 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99072341 |
| 107 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.98990547 |
| 108 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98417923 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98145154 |
| 110 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98032708 |
| 111 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.97749976 |
| 112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97116955 |
| 113 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96681622 |
| 114 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.96654413 |
| 115 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96606891 |
| 116 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96479356 |
| 117 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96468471 |
| 118 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95930461 |
| 119 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95812659 |
| 120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95179268 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94619423 |
| 122 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93566763 |
| 123 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93566763 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93229728 |
| 125 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93206158 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92199943 |
| 127 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89856348 |
| 128 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89829324 |
| 129 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88715918 |
| 130 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88388892 |
| 131 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88320478 |
| 132 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87062382 |
| 133 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86569847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.45104384 |
| 2 | MP0003880_abnormal_central_pattern | 5.16466007 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.11825666 |
| 4 | MP0009745_abnormal_behavioral_response | 3.60669932 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.55624438 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.22524250 |
| 7 | MP0003303_peritoneal_inflammation | 3.21531337 |
| 8 | MP0004270_analgesia | 3.19463976 |
| 9 | MP0009046_muscle_twitch | 3.17426369 |
| 10 | MP0002736_abnormal_nociception_after | 3.16588292 |
| 11 | MP0002735_abnormal_chemical_nociception | 3.14729422 |
| 12 | MP0002064_seizures | 3.14086612 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.81671868 |
| 14 | MP0002272_abnormal_nervous_system | 2.81070288 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.66640614 |
| 16 | MP0001188_hyperpigmentation | 2.43331348 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.40898073 |
| 18 | MP0002822_catalepsy | 2.28197835 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.19977948 |
| 20 | MP0001486_abnormal_startle_reflex | 2.19485575 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.15438931 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.04487934 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.04406315 |
| 24 | MP0003787_abnormal_imprinting | 2.04250911 |
| 25 | MP0008569_lethality_at_weaning | 2.04013437 |
| 26 | MP0005423_abnormal_somatic_nervous | 1.99746148 |
| 27 | MP0001970_abnormal_pain_threshold | 1.97948850 |
| 28 | MP0003690_abnormal_glial_cell | 1.90969846 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.86934847 |
| 30 | MP0003879_abnormal_hair_cell | 1.81996154 |
| 31 | MP0002184_abnormal_innervation | 1.79507943 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.65589950 |
| 33 | MP0004084_abnormal_cardiac_muscle | 1.64782113 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.60442941 |
| 35 | MP0000920_abnormal_myelination | 1.59607744 |
| 36 | MP0004924_abnormal_behavior | 1.55639436 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.55639436 |
| 38 | MP0005645_abnormal_hypothalamus_physiol | 1.48733852 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.46836877 |
| 40 | MP0001984_abnormal_olfaction | 1.45383280 |
| 41 | MP0006082_CNS_inflammation | 1.44827821 |
| 42 | MP0004858_abnormal_nervous_system | 1.42940065 |
| 43 | MP0005409_darkened_coat_color | 1.42865461 |
| 44 | MP0000566_synostosis | 1.41061186 |
| 45 | MP0003329_amyloid_beta_deposits | 1.40417437 |
| 46 | MP0004036_abnormal_muscle_relaxation | 1.38823810 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.35679316 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.32245848 |
| 49 | MP0004142_abnormal_muscle_tone | 1.31959766 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.30782150 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.29758856 |
| 52 | MP0001905_abnormal_dopamine_level | 1.29578439 |
| 53 | MP0000955_abnormal_spinal_cord | 1.28441749 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.26868854 |
| 55 | MP0004130_abnormal_muscle_cell | 1.25775527 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.25769843 |
| 57 | MP0003045_fibrosis | 1.25194073 |
| 58 | MP0001529_abnormal_vocalization | 1.22740407 |
| 59 | MP0008004_abnormal_stomach_pH | 1.22185238 |
| 60 | MP0000778_abnormal_nervous_system | 1.21739379 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.17133260 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.16555569 |
| 63 | MP0003633_abnormal_nervous_system | 1.16437954 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.16368040 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.16008773 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 1.12168081 |
| 67 | MP0004510_myositis | 1.10391993 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.09191737 |
| 69 | MP0005253_abnormal_eye_physiology | 1.07492645 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.03450227 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.03072989 |
| 72 | MP0002638_abnormal_pupillary_reflex | 0.97182821 |
| 73 | MP0003631_nervous_system_phenotype | 0.96925753 |
| 74 | MP0008874_decreased_physiological_sensi | 0.96050036 |
| 75 | MP0004742_abnormal_vestibular_system | 0.95881178 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.93511672 |
| 77 | MP0008872_abnormal_physiological_respon | 0.92425982 |
| 78 | MP0003122_maternal_imprinting | 0.92123668 |
| 79 | MP0003646_muscle_fatigue | 0.92047054 |
| 80 | MP0002229_neurodegeneration | 0.89914705 |
| 81 | MP0003724_increased_susceptibility_to | 0.89365901 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.87458409 |
| 83 | MP0001664_abnormal_digestion | 0.86841608 |
| 84 | MP0005535_abnormal_body_temperature | 0.86576852 |
| 85 | MP0001545_abnormal_hematopoietic_system | 0.85733541 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.85733541 |
| 87 | MP0004484_altered_response_of | 0.85558543 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.85071441 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.84105735 |
| 90 | MP0004885_abnormal_endolymph | 0.83223400 |
| 91 | MP0003075_altered_response_to | 0.81765062 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.80748972 |
| 93 | MP0005166_decreased_susceptibility_to | 0.80014417 |
| 94 | MP0000383_abnormal_hair_follicle | 0.79879073 |
| 95 | MP0002152_abnormal_brain_morphology | 0.79724698 |
| 96 | MP0009379_abnormal_foot_pigmentation | 0.79314159 |
| 97 | MP0005171_absent_coat_pigmentation | 0.78594492 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.76127919 |
| 99 | MP0004147_increased_porphyrin_level | 0.75333515 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.74970531 |
| 101 | MP0008877_abnormal_DNA_methylation | 0.72324387 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.71037554 |
| 103 | MP0000569_abnormal_digit_pigmentation | 0.69656589 |
| 104 | MP0001835_abnormal_antigen_presentation | 0.69431498 |
| 105 | MP0003136_yellow_coat_color | 0.69100342 |
| 106 | MP0000681_abnormal_thyroid_gland | 0.68563726 |
| 107 | MP0000343_altered_response_to | 0.67917189 |
| 108 | MP0004043_abnormal_pH_regulation | 0.65403049 |
| 109 | MP0005620_abnormal_muscle_contractility | 0.65051761 |
| 110 | MP0004085_abnormal_heartbeat | 0.64865336 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.64807582 |
| 112 | MP0002972_abnormal_cardiac_muscle | 0.64217464 |
| 113 | MP0000749_muscle_degeneration | 0.63787202 |
| 114 | MP0005394_taste/olfaction_phenotype | 0.63380056 |
| 115 | MP0005499_abnormal_olfactory_system | 0.63380056 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.62809427 |
| 117 | MP0003632_abnormal_nervous_system | 0.61787004 |
| 118 | MP0002095_abnormal_skin_pigmentation | 0.61721171 |
| 119 | MP0005671_abnormal_response_to | 0.61385556 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.61036447 |
| 121 | MP0002752_abnormal_somatic_nervous | 0.60084181 |
| 122 | MP0000751_myopathy | 0.59246599 |
| 123 | MP0000604_amyloidosis | 0.58505533 |
| 124 | MP0000631_abnormal_neuroendocrine_gland | 0.58449695 |
| 125 | MP0000013_abnormal_adipose_tissue | 0.55656310 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.54051133 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.51975628 |
| 128 | MP0001177_atelectasis | 0.51426056 |
| 129 | MP0002234_abnormal_pharynx_morphology | 0.50230686 |
| 130 | MP0000026_abnormal_inner_ear | 0.49412032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.18331824 |
| 2 | Visual hallucinations (HP:0002367) | 5.90068349 |
| 3 | Myokymia (HP:0002411) | 5.84012840 |
| 4 | Focal seizures (HP:0007359) | 5.76970388 |
| 5 | Febrile seizures (HP:0002373) | 5.66382509 |
| 6 | Atonic seizures (HP:0010819) | 5.32875790 |
| 7 | Epileptic encephalopathy (HP:0200134) | 5.15711492 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 5.14548853 |
| 9 | Absence seizures (HP:0002121) | 4.87339109 |
| 10 | Dialeptic seizures (HP:0011146) | 4.51130660 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 4.38181465 |
| 12 | Hyperventilation (HP:0002883) | 4.13999604 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.94647529 |
| 14 | Action tremor (HP:0002345) | 3.80476761 |
| 15 | Broad-based gait (HP:0002136) | 3.77956186 |
| 16 | Prolonged bleeding time (HP:0003010) | 3.75157322 |
| 17 | Truncal ataxia (HP:0002078) | 3.35986963 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.21210073 |
| 19 | Sudden death (HP:0001699) | 3.19376246 |
| 20 | Impaired smooth pursuit (HP:0007772) | 3.17523602 |
| 21 | Diplopia (HP:0000651) | 3.13029431 |
| 22 | Abnormality of binocular vision (HP:0011514) | 3.13029431 |
| 23 | Dysmetria (HP:0001310) | 3.11411848 |
| 24 | Progressive inability to walk (HP:0002505) | 3.09893575 |
| 25 | Depression (HP:0000716) | 3.06803058 |
| 26 | Purpura (HP:0000979) | 3.06464032 |
| 27 | Anxiety (HP:0000739) | 3.03499476 |
| 28 | Bundle branch block (HP:0011710) | 2.99274839 |
| 29 | Amblyopia (HP:0000646) | 2.98336960 |
| 30 | Menorrhagia (HP:0000132) | 2.92026204 |
| 31 | Scanning speech (HP:0002168) | 2.90923907 |
| 32 | Poor eye contact (HP:0000817) | 2.88434353 |
| 33 | Petechiae (HP:0000967) | 2.82562134 |
| 34 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.81957129 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 2.78099358 |
| 36 | Epistaxis (HP:0000421) | 2.71285657 |
| 37 | Absent speech (HP:0001344) | 2.70670974 |
| 38 | Drooling (HP:0002307) | 2.61397126 |
| 39 | Excessive salivation (HP:0003781) | 2.61397126 |
| 40 | Hemiparesis (HP:0001269) | 2.59916621 |
| 41 | Protruding tongue (HP:0010808) | 2.56180730 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.55929766 |
| 43 | Inability to walk (HP:0002540) | 2.54111661 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.54046502 |
| 45 | Epileptiform EEG discharges (HP:0011182) | 2.51346074 |
| 46 | Gingival bleeding (HP:0000225) | 2.51237490 |
| 47 | Genetic anticipation (HP:0003743) | 2.50305629 |
| 48 | Menstrual irregularities (HP:0000858) | 2.49505346 |
| 49 | Syncope (HP:0001279) | 2.47865727 |
| 50 | Impaired social interactions (HP:0000735) | 2.47810497 |
| 51 | Abnormal social behavior (HP:0012433) | 2.47810497 |
| 52 | Abnormal hair whorl (HP:0010721) | 2.45070604 |
| 53 | Tetraplegia (HP:0002445) | 2.44426621 |
| 54 | Decreased central vision (HP:0007663) | 2.39672987 |
| 55 | Large for gestational age (HP:0001520) | 2.39171180 |
| 56 | Postural instability (HP:0002172) | 2.37950228 |
| 57 | Bradykinesia (HP:0002067) | 2.36326360 |
| 58 | Hypothermia (HP:0002045) | 2.36096825 |
| 59 | Abnormal auditory evoked potentials (HP:0006958) | 2.35869556 |
| 60 | Papilledema (HP:0001085) | 2.35069850 |
| 61 | Mutism (HP:0002300) | 2.33866923 |
| 62 | Dysmetric saccades (HP:0000641) | 2.31140084 |
| 63 | Horizontal nystagmus (HP:0000666) | 2.31087265 |
| 64 | Hemiplegia (HP:0002301) | 2.28797355 |
| 65 | Stereotypic behavior (HP:0000733) | 2.26247978 |
| 66 | Limb ataxia (HP:0002070) | 2.24807627 |
| 67 | Status epilepticus (HP:0002133) | 2.23578946 |
| 68 | Psychosis (HP:0000709) | 2.21425269 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.19917651 |
| 70 | Postural tremor (HP:0002174) | 2.19420467 |
| 71 | Increased mean platelet volume (HP:0011877) | 2.18929572 |
| 72 | Generalized hypopigmentation of hair (HP:0011358) | 2.18084682 |
| 73 | Abnormal platelet volume (HP:0011876) | 2.17310953 |
| 74 | Ankle clonus (HP:0011448) | 2.17261349 |
| 75 | Spastic gait (HP:0002064) | 2.15701457 |
| 76 | Autoamputation (HP:0001218) | 2.14705902 |
| 77 | Decreased circulating renin level (HP:0003351) | 2.14692543 |
| 78 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.14159943 |
| 79 | Conjunctival telangiectasia (HP:0000524) | 2.11288577 |
| 80 | Fair hair (HP:0002286) | 2.09877185 |
| 81 | Increased circulating renin level (HP:0000848) | 2.09438264 |
| 82 | Atrial fibrillation (HP:0005110) | 2.09170906 |
| 83 | Retinal dysplasia (HP:0007973) | 2.08574845 |
| 84 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.07693754 |
| 85 | Gait imbalance (HP:0002141) | 2.06754748 |
| 86 | Fetal akinesia sequence (HP:0001989) | 2.06726791 |
| 87 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.06657361 |
| 88 | Hyperlipoproteinemia (HP:0010980) | 2.05790600 |
| 89 | Vertigo (HP:0002321) | 2.03895111 |
| 90 | Peripheral hypomyelination (HP:0007182) | 2.02274150 |
| 91 | Amyotrophic lateral sclerosis (HP:0007354) | 2.01540254 |
| 92 | Agitation (HP:0000713) | 2.01241742 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 1.99362943 |
| 94 | Gait ataxia (HP:0002066) | 1.98790626 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98380034 |
| 96 | Cerebral hypomyelination (HP:0006808) | 1.97040297 |
| 97 | Blue irides (HP:0000635) | 1.96300746 |
| 98 | Heart block (HP:0012722) | 1.96203400 |
| 99 | Primary atrial arrhythmia (HP:0001692) | 1.95907530 |
| 100 | Generalized myoclonic seizures (HP:0002123) | 1.94862367 |
| 101 | Impaired vibratory sensation (HP:0002495) | 1.94860913 |
| 102 | Intention tremor (HP:0002080) | 1.94166247 |
| 103 | Delusions (HP:0000746) | 1.94011039 |
| 104 | Congenital primary aphakia (HP:0007707) | 1.92994604 |
| 105 | Nonprogressive disorder (HP:0003680) | 1.91817393 |
| 106 | Medial flaring of the eyebrow (HP:0010747) | 1.91765352 |
| 107 | Nephrogenic diabetes insipidus (HP:0009806) | 1.91511161 |
| 108 | Hyporeflexia of lower limbs (HP:0002600) | 1.89635295 |
| 109 | Hypsarrhythmia (HP:0002521) | 1.89460426 |
| 110 | Acute lymphatic leukemia (HP:0006721) | 1.88854175 |
| 111 | Esotropia (HP:0000565) | 1.85697060 |
| 112 | Type II lissencephaly (HP:0007260) | 1.83449026 |
| 113 | Abnormality of salivation (HP:0100755) | 1.83116119 |
| 114 | Memory impairment (HP:0002354) | 1.82849096 |
| 115 | Supraventricular tachycardia (HP:0004755) | 1.82639518 |
| 116 | Spinal canal stenosis (HP:0003416) | 1.82499791 |
| 117 | Iris hypopigmentation (HP:0007730) | 1.82336829 |
| 118 | Cortical visual impairment (HP:0100704) | 1.80860659 |
| 119 | Unsteady gait (HP:0002317) | 1.80334138 |
| 120 | Widely spaced teeth (HP:0000687) | 1.80210085 |
| 121 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79608487 |
| 122 | Polyphagia (HP:0002591) | 1.78176769 |
| 123 | Abnormality of saccadic eye movements (HP:0000570) | 1.76194284 |
| 124 | Incomplete penetrance (HP:0003829) | 1.76113916 |
| 125 | Bradycardia (HP:0001662) | 1.75585893 |
| 126 | Ventricular arrhythmia (HP:0004308) | 1.74947945 |
| 127 | Muscle fiber splitting (HP:0003555) | 1.74700826 |
| 128 | Abnormal EKG (HP:0003115) | 1.74600074 |
| 129 | Torticollis (HP:0000473) | 1.74360984 |
| 130 | Hypokalemic alkalosis (HP:0001949) | 1.73852156 |
| 131 | Supraventricular arrhythmia (HP:0005115) | 1.73665266 |
| 132 | Neurofibrillary tangles (HP:0002185) | 1.72643236 |
| 133 | Ocular albinism (HP:0001107) | 1.72530387 |
| 134 | Abnormality of the lower motor neuron (HP:0002366) | 1.72430592 |
| 135 | Cerebral inclusion bodies (HP:0100314) | 1.71004641 |
| 136 | Inappropriate behavior (HP:0000719) | 1.70958087 |
| 137 | Decreased lacrimation (HP:0000633) | 1.70774589 |
| 138 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70749062 |
| 139 | Absent/shortened dynein arms (HP:0200106) | 1.70749062 |
| 140 | Thyroid-stimulating hormone excess (HP:0002925) | 1.70399616 |
| 141 | Annular pancreas (HP:0001734) | 1.68787010 |
| 142 | Lower limb muscle weakness (HP:0007340) | 1.68223386 |
| 143 | Thickened helices (HP:0000391) | 1.66809612 |
| 144 | Focal dystonia (HP:0004373) | 1.66650720 |
| 145 | Dysautonomia (HP:0002459) | 1.66286132 |
| 146 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.65955162 |
| 147 | Ventricular fibrillation (HP:0001663) | 1.65632438 |
| 148 | Macroglossia (HP:0000158) | 1.65176269 |
| 149 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.65003652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK2 | 6.30642574 |
| 2 | NTRK3 | 5.37381898 |
| 3 | EPHA4 | 4.08126014 |
| 4 | RIPK4 | 3.88105878 |
| 5 | MKNK1 | 3.16043497 |
| 6 | TNIK | 3.07754800 |
| 7 | MAP2K7 | 3.04461672 |
| 8 | FRK | 3.02141891 |
| 9 | MAP3K12 | 3.02109363 |
| 10 | CASK | 2.84163336 |
| 11 | MAP3K9 | 2.81349417 |
| 12 | MAP3K4 | 2.67824136 |
| 13 | TAOK1 | 2.62178177 |
| 14 | MINK1 | 2.56813009 |
| 15 | PRPF4B | 2.55478754 |
| 16 | FES | 2.20987128 |
| 17 | MAP2K3 | 2.16400106 |
| 18 | MAP3K11 | 2.08776220 |
| 19 | ARAF | 1.96683062 |
| 20 | MAP3K3 | 1.92864373 |
| 21 | DAPK1 | 1.88206830 |
| 22 | CAMKK2 | 1.87364532 |
| 23 | MAP3K13 | 1.82574310 |
| 24 | PLK2 | 1.80016455 |
| 25 | DAPK2 | 1.75019311 |
| 26 | MAP2K4 | 1.71163677 |
| 27 | KSR2 | 1.66036239 |
| 28 | GRK5 | 1.59938464 |
| 29 | CDK19 | 1.57376201 |
| 30 | MAP4K2 | 1.54653042 |
| 31 | JAK3 | 1.50049138 |
| 32 | CAMKK1 | 1.48022864 |
| 33 | BMPR2 | 1.47546448 |
| 34 | MUSK | 1.44633311 |
| 35 | PTK2B | 1.43557531 |
| 36 | NTRK1 | 1.38083397 |
| 37 | KSR1 | 1.35335361 |
| 38 | NTRK2 | 1.33725288 |
| 39 | NME1 | 1.33296207 |
| 40 | SIK2 | 1.30299459 |
| 41 | MYLK | 1.27894255 |
| 42 | CAMK1 | 1.25747081 |
| 43 | PRKCG | 1.25731914 |
| 44 | STK38 | 1.25615641 |
| 45 | CAMK2A | 1.24231830 |
| 46 | CDK5 | 1.23129715 |
| 47 | CAMK2B | 1.21730806 |
| 48 | MAPK13 | 1.18862963 |
| 49 | MAP3K5 | 1.18452522 |
| 50 | PDK2 | 1.14821126 |
| 51 | SIK3 | 1.13457056 |
| 52 | PNCK | 1.11870784 |
| 53 | STK16 | 1.10347962 |
| 54 | BLK | 1.08739675 |
| 55 | MARK1 | 1.08653597 |
| 56 | STK38L | 1.08367895 |
| 57 | PAK6 | 1.07503921 |
| 58 | PKN1 | 1.06672084 |
| 59 | RAF1 | 1.01463401 |
| 60 | PIK3CG | 0.97867285 |
| 61 | PAK3 | 0.97296885 |
| 62 | MAPK12 | 0.96969983 |
| 63 | TEC | 0.93370968 |
| 64 | TNK2 | 0.92987580 |
| 65 | TAOK3 | 0.89947785 |
| 66 | SGK2 | 0.86142550 |
| 67 | MAP3K2 | 0.84780901 |
| 68 | ABL2 | 0.83600527 |
| 69 | PHKG2 | 0.78553318 |
| 70 | PHKG1 | 0.78553318 |
| 71 | PINK1 | 0.78169413 |
| 72 | FGR | 0.77313235 |
| 73 | CAMK2D | 0.75594297 |
| 74 | DYRK1A | 0.74460403 |
| 75 | PRKD3 | 0.73529993 |
| 76 | TXK | 0.70953432 |
| 77 | FER | 0.70682893 |
| 78 | SGK223 | 0.69851270 |
| 79 | SGK494 | 0.69851270 |
| 80 | MAP3K1 | 0.67888018 |
| 81 | PRKCQ | 0.64460219 |
| 82 | ITK | 0.63992831 |
| 83 | GRK7 | 0.63627121 |
| 84 | TAOK2 | 0.63189397 |
| 85 | BTK | 0.62582448 |
| 86 | SGK1 | 0.62522384 |
| 87 | PRKCE | 0.60834613 |
| 88 | BRAF | 0.59323090 |
| 89 | SYK | 0.59062060 |
| 90 | CDK18 | 0.58741964 |
| 91 | CAMK2G | 0.58642117 |
| 92 | CDK14 | 0.57770512 |
| 93 | PIK3CA | 0.57292912 |
| 94 | AKT3 | 0.56857798 |
| 95 | MATK | 0.54954053 |
| 96 | GRK6 | 0.54520429 |
| 97 | CDK15 | 0.54151283 |
| 98 | WNK1 | 0.52889545 |
| 99 | JAK2 | 0.52106224 |
| 100 | MAPK7 | 0.51511108 |
| 101 | JAK1 | 0.49979001 |
| 102 | CAMK4 | 0.49185688 |
| 103 | OXSR1 | 0.48911589 |
| 104 | ADRBK2 | 0.48645913 |
| 105 | CDK11A | 0.48605681 |
| 106 | PDK1 | 0.48261861 |
| 107 | LYN | 0.46974178 |
| 108 | STK11 | 0.46344010 |
| 109 | CCNB1 | 0.45945894 |
| 110 | SGK3 | 0.45301224 |
| 111 | HCK | 0.45003445 |
| 112 | BMX | 0.43620819 |
| 113 | PRKD2 | 0.43575242 |
| 114 | CSF1R | 0.41827921 |
| 115 | PRKD1 | 0.41618180 |
| 116 | FYN | 0.41319398 |
| 117 | NEK6 | 0.40261583 |
| 118 | UHMK1 | 0.39964405 |
| 119 | ZAP70 | 0.38212841 |
| 120 | PRKG1 | 0.37324854 |
| 121 | PDPK1 | 0.37178958 |
| 122 | MAP3K6 | 0.37130045 |
| 123 | INSRR | 0.36635626 |
| 124 | ROCK1 | 0.36604238 |
| 125 | PRKACG | 0.35963762 |
| 126 | PRKACA | 0.35004076 |
| 127 | PRKCA | 0.33932561 |
| 128 | PRKCH | 0.33593474 |
| 129 | CDK3 | 0.32590764 |
| 130 | RPS6KA3 | 0.32123955 |
| 131 | LMTK2 | 0.29776290 |
| 132 | MAPK10 | 0.29107509 |
| 133 | CSNK1G2 | 0.26849588 |
| 134 | PRKCB | 0.26497274 |
| 135 | MOS | 0.26307160 |
| 136 | MAP3K7 | 0.24674013 |
| 137 | RET | 0.24299705 |
| 138 | KIT | 0.23727651 |
| 139 | MAP2K1 | 0.22666697 |
| 140 | MARK2 | 0.22624261 |
| 141 | PRKCZ | 0.22378680 |
| 142 | YES1 | 0.21100118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.60814498 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.16234022 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.10826236 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 3.10455496 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.87137872 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.81564515 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.67073721 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66729414 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.56986197 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51074195 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.36919644 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.28514193 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 2.14221984 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08742386 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.07906215 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.01525303 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.97617345 |
| 18 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.91395293 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.87967451 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.87488556 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80432626 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76858558 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.74047681 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.73216228 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.62722231 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51208527 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.45026664 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38987439 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36349508 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34353127 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32689744 |
| 32 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.30252557 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28904743 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27864391 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27536414 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22728545 |
| 37 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.22041119 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12849796 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.07612545 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.07515932 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04786570 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04285743 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98778339 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98632583 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97997980 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97770345 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95539217 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92789000 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91226266 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91155395 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.90657685 |
| 52 | Glioma_Homo sapiens_hsa05214 | 0.87434357 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87356895 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85670489 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84213472 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.82452780 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81719353 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80170445 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.78789096 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76997842 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73039263 |
| 62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72592416 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70263780 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70128682 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68494520 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67121346 |
| 67 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66542949 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65862175 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.65726701 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64900060 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64506496 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63910493 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63609776 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62969563 |
| 75 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61230422 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59368087 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57607858 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56561537 |
| 79 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55946955 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55785291 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54707542 |
| 82 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53616721 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53582385 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.53402488 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53077982 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52531202 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51583073 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48495342 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46846844 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45152485 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44303080 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.42889442 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42803565 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42493158 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41865402 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41459401 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40914024 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40132640 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40131235 |
| 100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.38260804 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38188763 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38133698 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37975345 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.36537098 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.36107478 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35412180 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34521180 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.31886954 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.30512490 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28958193 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.28381702 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28316841 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28137413 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26779605 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.26777324 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26115451 |
| 117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.26028272 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24446395 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.23294748 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23124357 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.22402421 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.22196717 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.21610608 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.20311546 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.19703918 |
| 126 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.17109423 |

